|
Dr. Martin joined Gilead Sciences in 1990 and has served as President and Chief Executive Officer since 1996. Prior to joining Gilead Dr. Martin held several leadership positions in the antiviral chemistry division at Bristol-Myers Squibb and served for six years with Syntex Corporation from 1978 until 1984.
Dr. Martin is a member of the Presidential Advisory Council on HIV/AIDS the Board of Directors of Gen-Probe Incorporated and the Board of Directors of the California Healthcare Institute. He also serves on the Centers for Disease Control/Health Resources and Services Administration's Advisory Committee on HIV and STD Prevention and Treatment and is a member of the Board of Trustees at the University of Chicago.
Dr. Martin holds a PhD in organic chemistry from the University of Chicago and an MBA in marketing from Golden Gate University. He has received the Isbell Award from the American Chemical Society and the Gertrude B. Elion Award for Scientific Excellence from the International Society for Antiviral Research. | 